United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72189-392_2c4ce258-41dc-b1b7-e063-6394a90aa5f3
- Product NDC
- 72189-392
- Form
- CAPSULE
- Composition / generic term
- Gabapentin
- Labeler
- Direct_Rx
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221116
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (72189-392-30) · 72189-392-30
- 60 CAPSULE in 1 BOTTLE (72189-392-60) · 72189-392-60
- 120 CAPSULE in 1 BOTTLE (72189-392-72) · 72189-392-72
- 180 CAPSULE in 1 BOTTLE (72189-392-82) · 72189-392-82
- 90 CAPSULE in 1 BOTTLE (72189-392-90) · 72189-392-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →